North Star Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.69M Sell
8,365
-181
-2% -$183K 0.47% 44
2025
Q4
$9.18M Buy
8,546
+363
+4% +$347K 0.58% 35
2025
Q3
$6.24M Buy
8,183
+22
+0.3% +$16.4K 0.4% 52
2025
Q2
$6.36M Sell
8,161
-27
-0.3% -$21K 0.44% 45
2025
Q1
$6.76M Sell
8,188
-295
-3% -$245K 0.49% 43
2024
Q4
$6.55M Sell
8,483
-374
-4% -$310K 0.46% 46
2024
Q3
$7.85M Buy
8,857
+18
+0.2% +$16.2K 0.54% 41
2024
Q2
$8M Sell
8,839
-669
-7% -$535K 0.59% 37
2024
Q1
$7.4M Buy
9,508
+500
+6% +$356K 0.53% 41
2023
Q4
$5.25M Sell
9,008
-110
-1% -$64.2K 0.4% 62
2023
Q3
$4.9M Sell
9,118
-205
-2% -$106K 0.41% 60
2023
Q2
$4.37M Buy
9,323
+55
+0.6% +$23.1K 0.35% 68
2023
Q1
$3.18M Buy
9,268
+835
+10% +$282K 0.26% 102
2022
Q4
$3.09M Buy
8,433
+128
+2% +$45.4K 0.27% 100
2022
Q3
$2.69M Buy
8,305
+1
+0% +$317 0.26% 97
2022
Q2
$2.69M Buy
8,304
+104
+1% +$31.2K 0.24% 103
2022
Q1
$2.35M Buy
8,200
+201
+3% +$51.7K 0.18% 132
2021
Q4
$2.21M Sell
7,999
-132
-2% -$33.5K 0.15% 137
2021
Q3
$1.88M Hold
8,131
0.15% 147
2021
Q2
$1.87M Sell
8,131
-39
-0.5% -$7.83K 0.15% 153
2021
Q1
$1.53M Sell
8,170
-55
-0.7% -$10.8K 0.14% 158
2020
Q4
$1.39M Sell
8,225
-25
-0.3% -$3.73K 0.14% 161
2020
Q3
$1.22M Hold
8,250
0.14% 154
2020
Q2
$1.35M Sell
8,250
-1,390
-14% -$213K 0.18% 139
2020
Q1
$1.34M Sell
9,640
-5,268
-35% -$724K 0.2% 131
2019
Q4
$1.96M Sell
14,908
-62
-0.4% -$7.19K 0.2% 126
2019
Q3
$1.67M Hold
14,970
0.19% 138
2019
Q2
$1.66M Hold
14,970
0.19% 140
2019
Q1
$1.94M Buy
14,970
+60
+0.4% +$7.3K 0.23% 125
2018
Q4
$1.73M Hold
14,910
0.23% 126
2018
Q3
$1.6M Hold
14,910
0.18% 152
2018
Q2
$1.27M Hold
14,910
0.15% 182
2018
Q1
$1.15M Buy
14,910
+390
+3% +$31.4K 0.14% 192
2017
Q4
$1.23M Buy
14,520
+470
+3% +$40K 0.15% 175
2017
Q3
$1.2M Buy
14,050
+4,900
+54% +$402K 0.15% 164
2017
Q2
$753K Hold
9,150
0.1% 214
2017
Q1
$770K Buy
9,150
+550
+6% +$44.1K 0.11% 199
2016
Q4
$633K Buy
8,600
+1,400
+19% +$104K 0.1% 211
2016
Q3
$578K Hold
7,200
0.1% 196
2016
Q2
$567K Hold
7,200
0.1% 201
2016
Q1
$518K Hold
7,200
0.1% 206
2015
Q4
$607K Hold
7,200
0.12% 190
2015
Q3
$603K Hold
7,200
0.12% 190
2015
Q2
$601K Hold
7,200
0.11% 199
2015
Q1
$523K Hold
7,200
0.1% 212
2014
Q4
$497K Hold
7,200
0.09% 209
2014
Q3
$467K Hold
7,200
0.09% 205
2014
Q2
$448K Hold
7,200
0.09% 210
2014
Q1
$424K Hold
7,200
0.09% 213
2013
Q4
$367K Buy
7,200
+1,200
+20% +$60.1K 0.08% 239
2013
Q3
$302K Hold
6,000
0.08% 229
2013
Q2
$295K Buy
+6,000
New +$326K 0.08% 225

Other funds holding LLY

North Star Investment Management's LLY Position: Q1 2026 in Review

North Star Investment Management reduced its Eli Lilly (LLY) stake by 2.1% in Q1 2026, selling an estimated $183K and leaving 8,365 shares worth $7.69M. The position accounts for 0.47% of the portfolio, ranked #44.

North Star Investment Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.18M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • North Star Investment Management held 8,365 shares of Eli Lilly worth $7.69M as of Q1 2026.
  • North Star Investment Management sold 181 Eli Lilly shares in Q1 2026, an estimated $183K.
  • Eli Lilly made up 0.47% of North Star Investment Management's portfolio in Q1 2026, its #44 holding.
  • North Star Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • North Star Investment Management's Eli Lilly position peaked at $9.18M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.